Mcrae Capital Management Inc Novo Cure LTD Transaction History

Mcrae Capital Management Inc

  • $452 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021
SELL
$116.17 - $194.55 $116,170 - $194,550
-1,000 Closed
0 $0
Q2 2021

Jul 28, 2021
BUY
$130.4 - $225.58 $130,400 - $225,580
1,000 New
1,000 $222,000

Others Institutions Holding NVCR

# of Institutions
277
Shares Held
73.2M
Call Options Held
1.43M
Put Options Held
832K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.76B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Mcrae Capital Management Inc Portfolio

Follow Mcrae Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email